Journal
CANCER RESEARCH
Volume 67, Issue 13, Pages 6003-6006Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-07-1543
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA114425-01, P50 CA098252, P50 CA098252-02, U19 CA113341-01, U19 CA113341, R01 CA114425, 1P50 CA098252-02, 1R01 CA114425-01] Funding Source: Medline
Ask authors/readers for more resources
Tumor immune escape is a critical trait of cancer but the mechanisms involved have yet to fully emerge. One recent study has shown that tumor cells can escape T-cell immunity by overexpressing the endothelial cell adhesion molecule vascular cell adhesion molecule-1 (VCAM-1), which normally mediates leukocyte extravasion to sites of tissue inflammation. Renal cell carcinoma (RCC) was identified as one tumor type where VCAM-1 is commonly highly overexpressed. Together, our findings suggest that RCCs might exploit VCAM-1. overexpression for immune escape.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available